M. AYDIN ASLAN Et Al. , "Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients," FEBS OPEN BIO , vol.8, pp.278-279, 2018
AYDIN ASLAN, M. Et Al. 2018. Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients. FEBS OPEN BIO , vol.8 , 278-279.
AYDIN ASLAN, M., Kirac, E., Kaya, S., Ozcan, F., Salim, O., & Kupesiz, O. A., (2018). Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients. FEBS OPEN BIO , vol.8, 278-279.
AYDIN ASLAN, MUTAY Et Al. "Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients," FEBS OPEN BIO , vol.8, 278-279, 2018
AYDIN ASLAN, MUTAY A. Et Al. "Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients." FEBS OPEN BIO , vol.8, pp.278-279, 2018
AYDIN ASLAN, M. Et Al. (2018) . "Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients." FEBS OPEN BIO , vol.8, pp.278-279.
@article{article, author={MUTAY AYDIN ASLAN Et Al. }, title={Sphingolipidomic analysis reveals decreased levels of very long chain sphingomyelins and ceramides in sickle cell disease patients}, journal={FEBS OPEN BIO}, year=2018, pages={278-279} }